Trump administration economic projects like its big AI build-out involve billions of dollars in investments from the Saudi ...
Baird analyst Joel Beatty initiated coverage of Catalyst Pharmaceuticals (CPRX) with an Outperform rating and $28 price target Maximize Your ...
Catalyst Capital Advisors LLC, a leading provider of alternative and innovative investment solutions, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback